Summary & Overview
CPT 93893: Contrast-Enhanced Transcranial Doppler for Shunt Evaluation
CPT code 93893 designates a contrast-enhanced transcranial Doppler ultrasound used to evaluate intracranial arterial blood flow and to detect venous–arterial shunts. The procedure uses Doppler imaging of intracranial arteries with microbubble contrast to improve visualization of flow dynamics, aiding diagnosis of right-to-left or other arteriovenous communications. Nationally, this code is relevant for cerebrovascular diagnostic pathways, stroke workups, and selected neurovascular evaluations where noninvasive detection of shunting affects clinical management.
Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for contrast-enhanced transcranial Doppler studies, common sites of service, and standard billing considerations tied to this procedure. The publication outlines typical use cases, where this modality fits alongside other neurovascular imaging options, and what to expect in payer coverage and claims processing at a high level.
This summary serves clinicians, coding staff, and policy analysts seeking concise information on the procedure represented by CPT code 93893, how it is used clinically to detect venous–arterial shunts, and which national payers commonly cover or process claims for this service.
Billing Code Overview
CPT code 93893 describes a contrast-enhanced transcranial Doppler ultrasound study of intracranial arteries. The provider performs Doppler ultrasound of the arteries inside the head with injection of a microbubble (contrast) to enhance imaging. The study is performed to evaluate flow dynamics and to detect a venous–arterial shunt (an abnormal connection between the venous and arterial systems).
Service type: Contrast-enhanced transcranial Doppler ultrasound
Typical site of service: Hospital outpatient department, outpatient imaging center, or other facility capable of ultrasound with contrast and transcranial access
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult referred to vascular neurology or diagnostic vascular ultrasound after a cryptogenic ischemic stroke or transient ischemic attack when a venous–arterial (right-to-left) shunt such as a patent foramen ovale (PFO) or pulmonary arteriovenous malformation is suspected. The patient often presents with acute focal neurologic deficits or transient neurologic symptoms and has completed initial brain imaging (CT or MRI) and standard cardiac evaluation (ECG, transthoracic echocardiogram). The provider orders a contrast-enhanced transcranial Doppler (TCD) bubble study to detect microbubbles crossing from the venous to arterial circulation.
Workflow:
-
Referral and indication documented in the medical record by the ordering neurologist or primary team.
-
Patient screening for contraindications to intravenous microbubble contrast (allergy to contrast agent or right-to-left shunt that precludes safe injection per facility policy).
-
Informed consent obtained and IV access established.
-
Registered vascular technologist or sonographer positions the transducer over the temporal bone window and acquires baseline Doppler signals from the middle cerebral artery.
-
The provider (physician or credentialed practitioner) injects agitated saline or FDA-cleared microbubble contrast while the patient performs provocative maneuvers (Valsalva) as indicated.
-
Real-time Doppler monitoring for high-intensity transient signals to document number and timing of microbubbles; the provider interprets and documents presence, timing (early vs late), and grade of shunt.
-
Results communicated to the ordering clinician; documentation includes indication, technique, contrast used, maneuvers, results, and any complications.